1. What Is Alzheimer’s Disease, Really?
Alzheimer’s is not simply “forgetting things.” It’s a progressive neurodegenerative disease that affects memory, processing speed, executive function, language, and ultimately the ability to perform daily tasks. It’s also the most common form of dementia, affecting millions of Americans. Up to 47 million people may already have preclinical Alzheimer’s, meaning the disease is present in the brain with no symptoms yet visible.
That last number should stop you in your tracks. And it should also empower you, because preclinical means there is still time to intervene.
2. The AGE Framework: Why Some People Get Alzheimer’s Even When They Do Everything Right
One of the most important concepts I want my patients to understand is the AGE framework: Age, Genetics, and Environment.
- Age is the single greatest risk factor. The longer you live, the greater the likelihood of amyloid accumulation in the brain.
- Genetics plays a significant role, particularly the APOE gene. The APOE e4 variant increases Alzheimer’s risk, and carrying two copies of this variant raises risk considerably. However, and this is critical, having the APOE e4 gene does not mean you will get Alzheimer’s. Genetics loads the gun; lifestyle pulls the trigger.
- Environment is where your power lies. Epigenetics, how your environment interacts with your genome, can push you toward or away from Alzheimer’s. One in three cases of Alzheimer’s may be preventable through lifestyle modification. That is not a small number. That is an enormous opportunity.
3. Understanding Your Genetic Risk
The APOE gene comes in three major variants: e2, e3, and e4. You inherit one copy from each parent, giving you one of six possible combinations. The e3/e3 combination is considered standard risk. The e4/e4 combination carries the highest associated risk.
But genetics is never the whole story. Other genes, including variants of the TNF gene and MTHFR, can compound risk in ways that aren’t obvious from APOE status alone. This is why a personalized, precision medicine approach is essential. Knowing your genotype gives us a map. What we do with that map is where the real work begins.
One gene worth understanding is MTHFR, methylenetetrahydrofolate reductase. Certain variants of this gene can lead to elevated homocysteine levels and impaired B vitamin metabolism, both of which have been linked to brain atrophy and memory decline. The good news: targeted supplementation with methylated B12 and methyl folate, combined with optimized omega-3 fatty acids, can help bring these markers into range and slow cognitive decline.